References
- Beckett A.H., Boyes R.N., Appleton P.J. The metabolism and excretion of lignocaine in man. Journal of Pharmacy and Pharmacology 1966; 18(supplement)76S–81S
- Goto S., Itano J. Hydrolysis of lidocaine and it's metabolites. Yakugaku Zasshi 1979; 99: 146–154
- Heinonen J. Influence of some drugs on the toxicity and rate of metabolism of lidocaine and mepivacaine. Annals of Medicine Experimental of Finland 1966; 44(supplement 3)7–43
- Hollunger G. Solubilisation and purification of an amide-hydrolysing microsomal enzyme. Acta Pharmacologia et Toxicologia 1960a; 17: 374–383
- Hollunger G. On the metabolism of lidocaine. II. The biotransformation of lidocaine. Acta Pharmacologica et Toxicologia 1960b; 17: 365–373
- Kammerer R.C., Schmitz D.A. The biotransformation of lidocaine and detection of a new metabolite. Federation Proceedings of the Federation of American Societies of Experimental Biology 1985; 44: 1253
- Kammerer R.C., Schmitz D.A., Di Stefano E.W., Cho A.K. The metabolism of phencyclidine by rabbit liver preparations. Drug Metabolism & Disposition 1981; 9: 274–278
- Keenaghan J.B., Boyes R.N. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. Journal of Pharmacology and Experimental Therapeutics 1972; 180: 454–463
- Lindstrom H.V., Hansen W.H., Nelson A.A., Fitzhugh O.G. The metabolism of FD&C red #1. II. The fate of 2,5-para-xylidine and 2,6-meta-xylidine in rats and observations on the toxicity of xylidine isomers. Journal of Pharmacology and Experimented Therapeutics 1963; 142: 257–264
- Nelson S.D., Nelson W.L., Trager W.F. N-hydroxyamide metabolites of lidocaine. Synthesis, characterization, quantitation & mutagenic potential. Journal of Medicinal Chemistry 1978; 21: 721–725
- Nohmi T., Miyata R., Yoshikawa K., Nakadate V., Isidate M. Metabolic activation of 2,4-xylidine and its mutagenic metabolite. Biochemical Pharmacology 1983; 32: 735–738